BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pang L, Khan F, Heimberger AB, Chen P. Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma. Trends Cancer 2022:S2405-8033(22)00097-8. [PMID: 35624002 DOI: 10.1016/j.trecan.2022.04.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Khan F, Pang L, Dunterman M, Lesniak MS, Heimberger AB, Chen P. Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy. J Clin Invest 2023;133. [PMID: 36594466 DOI: 10.1172/JCI163446] [Reference Citation Analysis]
2 Zhang X, Zhao L, Zhang H, Zhang Y, Ju H, Wang X, Ren H, Zhu X, Dong Y. The immunosuppressive microenvironment and immunotherapy in human glioblastoma. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1003651] [Reference Citation Analysis]
3 Yu Y, Huang Y, Li C, Ou S, Xu C, Kang Z. Clinical value of M1 macrophage-related genes identification in bladder urothelial carcinoma and in vitro validation. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1047004] [Reference Citation Analysis]
4 Sun S, Gu W, Wu H, Zhao Q, Qian S, Xiao H, Yang K, Liu J, Jin Y, Hu C, Gao Y, Xu H, Liu H, Ji J, Chen Y. Immunostimulant In Situ Hydrogel Improves Synergetic Radioimmunotherapy of Malignant Glioblastoma Relapse Post‐Resection. Adv Funct Materials. [DOI: 10.1002/adfm.202205038] [Reference Citation Analysis]